Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2017-2028

2.1.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Segment by Type

2.2.1 Sildenafil

2.2.2 Tadalafil

2.2.3 Avanafil

2.2.4 Vardenafil

2.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type

2.3.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Type (2017-2022)

2.4 Phosphodiesterase Type 5 (PDE5) Inhibitor Segment by Application

2.4.1 Hospital

2.4.2 Retail Pharmacy

2.4.3 Online Pharmacies

2.4.4 Other

2.5 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application

2.5.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Application (2017-2022)

3 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Player

3.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Players

3.1.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Players (2020-2022)

3.1.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Players (2020-2022)

3.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Phosphodiesterase Type 5 (PDE5) Inhibitor by Regions

4.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Regions (2017-2022)

4.2 Americas Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth (2017-2022)

4.3 APAC Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth (2017-2022)

4.4 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth (2017-2022)

4.5 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth (2017-2022)

5 Americas

5.1 Americas Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2017-2022)

5.2 Americas Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022)

5.3 Americas Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2017-2022)

6.2 APAC Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022)

6.3 APAC Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor by Country (2017-2022)

7.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022)

7.3 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor by Region (2017-2022)

8.2 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022)

8.3 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecast by Regions (2023-2028)

10.1.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecast by Regions (2023-2028)

10.1.2 Americas Phosphodiesterase Type 5 (PDE5) Inhibitor Forecast

10.1.3 APAC Phosphodiesterase Type 5 (PDE5) Inhibitor Forecast

10.1.4 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Forecast

10.1.5 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Forecast

10.2 Americas Phosphodiesterase Type 5 (PDE5) Inhibitor Forecast by Country (2023-2028)

10.2.1 United States Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.2.2 Canada Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.2.3 Mexico Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.2.4 Brazil Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.3 APAC Phosphodiesterase Type 5 (PDE5) Inhibitor Forecast by Region (2023-2028)

10.3.1 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.3.2 Japan Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.3.3 Korea Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.3.4 Southeast Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.3.5 India Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.3.6 Australia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.4 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Forecast by Country (2023-2028)

10.4.1 Germany Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.4.2 France Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.4.3 UK Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.4.4 Italy Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.4.5 Russia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.5 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Forecast by Region (2023-2028)

10.5.1 Egypt Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.5.2 South Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.5.3 Israel Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.5.4 Turkey Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.5.5 GCC Countries Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast

10.6 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecast by Type (2023-2028)

10.7 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Eli Lilly

11.1.1 Eli Lilly Company Information

11.1.2 Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

11.1.3 Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Eli Lilly Main Business Overview

11.1.5 Eli Lilly Latest Developments

11.2 Pfizer

11.2.1 Pfizer Company Information

11.2.2 Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

11.2.3 Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Pfizer Main Business Overview

11.2.5 Pfizer Latest Developments

11.3 Bayer

11.3.1 Bayer Company Information

11.3.2 Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

11.3.3 Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Bayer Main Business Overview

11.3.5 Bayer Latest Developments

11.4 Novartis AG

11.4.1 Novartis AG Company Information

11.4.2 Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

11.4.3 Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Novartis AG Main Business Overview

11.4.5 Novartis AG Latest Developments

11.5 Merck

11.5.1 Merck Company Information

11.5.2 Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

11.5.3 Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Merck Main Business Overview

11.5.5 Merck Latest Developments

11.6 GlaxoSmithKline plc

11.6.1 GlaxoSmithKline plc Company Information

11.6.2 GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

11.6.3 GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 GlaxoSmithKline plc Main Business Overview

11.6.5 GlaxoSmithKline plc Latest Developments

11.7 Roche

11.7.1 Roche Company Information

11.7.2 Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

11.7.3 Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Roche Main Business Overview

11.7.5 Roche Latest Developments

11.8 AstraZeneca

11.8.1 AstraZeneca Company Information

11.8.2 AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

11.8.3 AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 AstraZeneca Main Business Overview

11.8.5 AstraZeneca Latest Developments

11.9 BaiYunShan General Factory

11.9.1 BaiYunShan General Factory Company Information

11.9.2 BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

11.9.3 BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 BaiYunShan General Factory Main Business Overview

11.9.5 BaiYunShan General Factory Latest Developments

11.10 SK Chemicals

11.10.1 SK Chemicals Company Information

11.10.2 SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

11.10.3 SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 SK Chemicals Main Business Overview

11.10.5 SK Chemicals Latest Developments

11.11 Teva Pharma

11.11.1 Teva Pharma Company Information

11.11.2 Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

11.11.3 Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Teva Pharma Main Business Overview

11.11.5 Teva Pharma Latest Developments

11.12 Dong-A ST

11.12.1 Dong-A ST Company Information

11.12.2 Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

11.12.3 Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Dong-A ST Main Business Overview

11.12.5 Dong-A ST Latest Developments

11.13 Metuchen Pharma

11.13.1 Metuchen Pharma Company Information

11.13.2 Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

11.13.3 Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Metuchen Pharma Main Business Overview

11.13.5 Metuchen Pharma Latest Developments

11.14 Seoul Pharma

11.14.1 Seoul Pharma Company Information

11.14.2 Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

11.14.3 Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Seoul Pharma Main Business Overview

11.14.5 Seoul Pharma Latest Developments

11.15 Vectura Group

11.15.1 Vectura Group Company Information

11.15.2 Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

11.15.3 Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Vectura Group Main Business Overview

11.15.5 Vectura Group Latest Developments

12 Research Findings and Conclusion

Table 1. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Sildenafil

Table 3. Major Players of Tadalafil

Table 4. Major Players of Avanafil

Table 5. Major Players of Vardenafil

Table 6. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Type (2017-2022)

Table 9. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Application (2017-2022)

Table 12. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Player (2020-2022)

Table 14. Phosphodiesterase Type 5 (PDE5) Inhibitor Key Players Head office and Products Offered

Table 15. Phosphodiesterase Type 5 (PDE5) Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Regions (2017-2022)

Table 20. Americas Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Country (2017-2022)

Table 22. Americas Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Type (2017-2022)

Table 24. Americas Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Application (2017-2022)

Table 26. APAC Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Region (2017-2022)

Table 28. APAC Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Type (2017-2022)

Table 30. APAC Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Application (2017-2022)

Table 32. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Country (2017-2022)

Table 34. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Type (2017-2022)

Table 36. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Phosphodiesterase Type 5 (PDE5) Inhibitor

Table 45. Key Market Challenges & Risks of Phosphodiesterase Type 5 (PDE5) Inhibitor

Table 46. Key Industry Trends of Phosphodiesterase Type 5 (PDE5) Inhibitor

Table 47. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share Forecast by Application (2023-2028)

Table 53. Eli Lilly Details, Company Type, Phosphodiesterase Type 5 (PDE5) Inhibitor Area Served and Its Competitors

Table 54. Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

Table 55. Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Eli Lilly Main Business

Table 57. Eli Lilly Latest Developments

Table 58. Pfizer Details, Company Type, Phosphodiesterase Type 5 (PDE5) Inhibitor Area Served and Its Competitors

Table 59. Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

Table 60. Pfizer Main Business

Table 61. Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Pfizer Latest Developments

Table 63. Bayer Details, Company Type, Phosphodiesterase Type 5 (PDE5) Inhibitor Area Served and Its Competitors

Table 64. Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

Table 65. Bayer Main Business

Table 66. Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Bayer Latest Developments

Table 68. Novartis AG Details, Company Type, Phosphodiesterase Type 5 (PDE5) Inhibitor Area Served and Its Competitors

Table 69. Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

Table 70. Novartis AG Main Business

Table 71. Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Novartis AG Latest Developments

Table 73. Merck Details, Company Type, Phosphodiesterase Type 5 (PDE5) Inhibitor Area Served and Its Competitors

Table 74. Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

Table 75. Merck Main Business

Table 76. Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Merck Latest Developments

Table 78. GlaxoSmithKline plc Details, Company Type, Phosphodiesterase Type 5 (PDE5) Inhibitor Area Served and Its Competitors

Table 79. GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

Table 80. GlaxoSmithKline plc Main Business

Table 81. GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. GlaxoSmithKline plc Latest Developments

Table 83. Roche Details, Company Type, Phosphodiesterase Type 5 (PDE5) Inhibitor Area Served and Its Competitors

Table 84. Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

Table 85. Roche Main Business

Table 86. Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Roche Latest Developments

Table 88. AstraZeneca Details, Company Type, Phosphodiesterase Type 5 (PDE5) Inhibitor Area Served and Its Competitors

Table 89. AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

Table 90. AstraZeneca Main Business

Table 91. AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. AstraZeneca Latest Developments

Table 93. BaiYunShan General Factory Details, Company Type, Phosphodiesterase Type 5 (PDE5) Inhibitor Area Served and Its Competitors

Table 94. BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

Table 95. BaiYunShan General Factory Main Business

Table 96. BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. BaiYunShan General Factory Latest Developments

Table 98. SK Chemicals Details, Company Type, Phosphodiesterase Type 5 (PDE5) Inhibitor Area Served and Its Competitors

Table 99. SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

Table 100. SK Chemicals Main Business

Table 101. SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. SK Chemicals Latest Developments

Table 103. Teva Pharma Details, Company Type, Phosphodiesterase Type 5 (PDE5) Inhibitor Area Served and Its Competitors

Table 104. Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

Table 105. Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Teva Pharma Main Business

Table 107. Teva Pharma Latest Developments

Table 108. Dong-A ST Details, Company Type, Phosphodiesterase Type 5 (PDE5) Inhibitor Area Served and Its Competitors

Table 109. Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

Table 110. Dong-A ST Main Business

Table 111. Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. Dong-A ST Latest Developments

Table 113. Metuchen Pharma Details, Company Type, Phosphodiesterase Type 5 (PDE5) Inhibitor Area Served and Its Competitors

Table 114. Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

Table 115. Metuchen Pharma Main Business

Table 116. Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. Metuchen Pharma Latest Developments

Table 118. Seoul Pharma Details, Company Type, Phosphodiesterase Type 5 (PDE5) Inhibitor Area Served and Its Competitors

Table 119. Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

Table 120. Seoul Pharma Main Business

Table 121. Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 122. Seoul Pharma Latest Developments

Table 123. Vectura Group Details, Company Type, Phosphodiesterase Type 5 (PDE5) Inhibitor Area Served and Its Competitors

Table 124. Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Product Offered

Table 125. Vectura Group Main Business

Table 126. Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 127. Vectura Group Latest Developments

List of Figures

Figure 1. Phosphodiesterase Type 5 (PDE5) Inhibitor Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Type in 2021

Figure 7. Phosphodiesterase Type 5 (PDE5) Inhibitor in Hospital

Figure 8. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market: Hospital (2017-2022) & ($ Millions)

Figure 9. Phosphodiesterase Type 5 (PDE5) Inhibitor in Retail Pharmacy

Figure 10. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market: Retail Pharmacy (2017-2022) & ($ Millions)

Figure 11. Phosphodiesterase Type 5 (PDE5) Inhibitor in Online Pharmacies

Figure 12. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market: Online Pharmacies (2017-2022) & ($ Millions)

Figure 13. Phosphodiesterase Type 5 (PDE5) Inhibitor in Other

Figure 14. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market: Other (2017-2022) & ($ Millions)

Figure 15. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Application in 2021

Figure 16. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Player in 2021

Figure 17. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2017-2022 ($ Millions)

Figure 19. APAC Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2017-2022 ($ Millions)

Figure 20. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2017-2022 ($ Millions)

Figure 22. Americas Phosphodiesterase Type 5 (PDE5) Inhibitor Value Market Share by Country in 2021

Figure 23. Americas Phosphodiesterase Type 5 (PDE5) Inhibitor Consumption Market Share by Type in 2021

Figure 24. Americas Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Application in 2021

Figure 25. United States Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Region in 2021

Figure 30. APAC Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Application in 2021

Figure 31. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Country in 2021

Figure 38. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Type in 2021

Figure 39. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Application in 2021

Figure 40. Germany Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Application in 2021

Figure 48. Egypt Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 54. APAC Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 55. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 57. United States Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 58. Canada Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 61. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 62. Japan Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 63. Korea Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 65. India Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 66. Australia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 67. Germany Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 68. France Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 69. UK Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 70. Italy Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 71. Russia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 72. Spain Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 75. Israel Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2023-2028 ($ Millions)